← GILEAD SCIENCES, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $30.4b | $26.1b | $22.1b | $22.4b | $24.7b | $27.3b | $27.3b | $27.1b | $28.8b | $29.4b | |
| Cost of Revenue | $4.3b | $4.4b | $4.9b | $4.7b | $4.6b | $6.6b | $5.7b | $6.5b | $6.3b | $6.2b | |
| Cost of goods sold | $4.3b | $4.4b | $4.9b | $4.7b | $4.6b | $6.6b | $5.7b | $6.5b | $6.3b | $6.2b | |
| Gross Profit (Calculated) | $26.1b | $21.7b | $17.3b | $17.8b | $20.1b | $20.7b | $21.6b | $20.6b | $22.5b | $23.2b | |
| In-process research and development impairments | — | — | — | — | $0 | $0 | $2.7b | $50.0m | $4.2b | $590.0m | |
| Operating expenses: | |||||||||||
| Operating Income (Loss) | $17.6b | $14.1b | $8.2b | $4.3b | $4.1b | $9.9b | $7.3b | $7.6b | $1.7b | $10.0b | |
| Additional Financial Items | |||||||||||
| Amortization of Intangible Assets | — | — | — | — | — | — | $1.8b | $2.3b | $2.4b | $2.4b | |
| Fair Value, Option, Changes in Fair Value, Gain (Loss) | ($128.0m) | — | — | — | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $7.6b | $8.1b | $7.1b | $4.1b | $2.5b | $8.6b | $4.4b | $5.5b | ($876.0m) | $8.3b | |
| Net loss attributable to noncontrolling interest | ($13.0m) | $16.0m | $5.0m | ($22.0m) | ($34.0m) | $24.0m | $26.0m | $52.0m | $0 | $0 | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | $7.8b | $5.2b | $1.7b | $8.3b | $5.8b | $6.9b | $690.0m | $9.8b | |
| Income before income taxes | — | — | $7.8b | $5.2b | $1.7b | $8.3b | $5.8b | $6.9b | $690.0m | $9.8b | |
| Net Income (Loss) Attributable to Parent | $13.5b | $4.6b | $5.5b | $5.4b | $123.0m | $6.2b | $4.6b | $5.7b | $480.0m | $8.5b | |
| Net Income (Loss) Attributable to Noncontrolling Interest | ($13.0m) | $16.0m | $5.0m | ($22.0m) | ($34.0m) | ($24.0m) | ($26.0m) | ($52.0m) | $0 | $0 | |
| Common Stock, Dividends, Per Share, Declared | $1.84 | $2.08 | $2.28 | $2.52 | $2.72 | $2.84 | $2.92 | $0.75 | $3.08 | $3.16 | |
| Earnings Per Share, Basic | $10.08 | $3.54 | $4.20 | $4.24 | $0.10 | $4.96 | $3.66 | $4.54 | $0.38 | $6.84 | |
| Earnings Per Share, Diluted | $9.94 | $3.51 | $4.17 | $4.22 | $0.10 | $4.93 | $3.64 | $4.50 | $0.38 | $6.78 | |
| Weighted Average Number of Shares Outstanding, Basic | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | 1.2b | 1.2b | 1.2b | |
| Weighted Average Number of Shares Outstanding, Diluted | 1.4b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | |
| Acquired in-process research and development expenses | — | — | $1.1b | $5.1b | $5.9b | $177.0m | $944.0m | $1.2b | $4.7b | $1.0b | |
| Costs and Expenses | $12.8b | $12.0b | $13.9b | $18.2b | $20.6b | $17.4b | $20.0b | $19.5b | $27.1b | $19.4b | |
| Income tax (benefit) expense | $3.6b | $8.9b | $2.3b | ($204.0m) | $1.6b | ($2.1b) | ($1.2b) | ($1.2b) | $211.0m | $1.3b | |
| Interest Expense | $964.0m | $1.1b | $1.1b | $995.0m | $984.0m | $1.0b | $935.0m | $944.0m | $977.0m | $1.0b | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $977.0m | $1.0b | |
| Operating Lease, Expense | — | — | — | $162.0m | $171.0m | $156.0m | $162.0m | $165.0m | $163.0m | $169.0m | |
| Other (income) expense, net | $428.0m | $523.0m | $676.0m | $1.9b | ($1.4b) | ($639.0m) | ($581.0m) | $198.0m | ($6.0m) | ($798.0m) | |
| Other Nonoperating Income (Expense) | — | — | — | — | — | — | — | — | ($2.0m) | ($1.0m) | |
| Research and Development Expense | $5.1b | $3.7b | $5.0b | $9.1b | $5.0b | $5.4b | $5.0b | $5.7b | $5.9b | $5.8b | |
| Research and development expenses | $5.1b | $3.7b | $5.0b | $9.1b | $5.0b | $5.4b | $5.0b | $5.7b | $5.9b | $5.8b | |
| Selling, General and Administrative Expense | $3.4b | $3.9b | $4.1b | $4.4b | $5.2b | $5.2b | $5.7b | $6.1b | $6.1b | $5.8b | |
| Selling, general and administrative expenses | $3.4b | $3.9b | $4.1b | $4.4b | $5.2b | $5.2b | $5.7b | $6.1b | $6.1b | $5.8b | |
| Income Tax Expense (Benefit) | $3.6b | $8.9b | $2.3b | ($204.0m) | $1.6b | $2.1b | $1.2b | $1.2b | $211.0m | $1.3b | |
| Total costs and expenses | $12.8b | $12.0b | $13.9b | $18.2b | $20.6b | $17.4b | $20.0b | $19.5b | $27.1b | $19.4b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.